logo
15:50 Jun 25

Lasa Supergenerics Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
7.60
-0.06 (-0.78%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lasa Supergenerics Ltd. Financials

Lasa Supergenerics Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
7.60
-0.06 (-0.78%)
15:50 Jun 25
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

39/100
Technically Neutral

Strength

3

Weakness

8

Opportunity

0

Threats

0

-68.69 %

ROE %

-51.44 %

ROA %

-6.80

EPS

9.90

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
137.13 129.57 104.34 142.45 25.14
Operating Expenses +
121.49 136.16 102.17 136.18 32.5
Raw Material
94.46 110.12 79.28 108.1 19.15
Increase Decrease in Cost
-3.17 -4.01 -4.06 -1.91 4.69
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
9.93 7.37 6.34 6.11 2.17
Miscellaneous Expenses
32.77 22.68 20.61 23.88 6.49
Operating Profit
15.64 -6.59 2.17 6.27 -7.36
Other Income
0.06 1.8 0.1 5.01 0.2
Depreciation
14 13.42 10.67 12.3 6.02
Interest
0.04 4.16 1.93 2.69 0.39
Profit before tax and exceptio..
1.65 -22.37 -10.34 -3.71 -13.57
Exceptional Items
-7.86 -19.9 -8.77 -15.67 -21.04
PBT
-6.21 -42.27 -19.11 -19.38 -34.61
Provision for Taxation
-0.84 -3.64 2.62 -4.63 -0.52
Net Profit
-5.37 -38.62 -21.73 -14.76 -34.09
NET Profit after MI
0 0 0 0 0
EPS
-1.3 -7.71 -4.34 -2.95 -6.8
Operating Profit Margin (%)
11.41 -5.09 2.08 4.4 -29.28
Net Profit Margin (%)
-3.92 -29.81 -20.83 -10.36 -135.6

Lasa Supergenerics Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: